Studies on clinical marker enzymes in assessing the efficacy of Muthu Marunthu (a herbal formulation) on experimental fibrosarcoma in rats

Medical Science Research

Volumn 26, Issue 11, 1998, Pages 767-770

  Palani, V ^a  

^a ISLAMIAH COLLEGE   (India)

Author keywords

Anticancer effect; Fibrosarcoma; Herbal formulation; Muthu Marunthu

Indexed keywords

3 METHYLCHOLANTHRENE; ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MUTHU MARUNTHU; PLANT EXTRACT; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSARCOMA; HERBAL MEDICINE; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

ANIMALIA;

EID: 0031798203     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkinson DR. Arbuck SO. Moore T, Pluda JM, Christian MC. Clinical development of anticancer agents from natural products. Stem cells 1994: 12: 30-43.
2. Sugie S. Okamoto K. Rahman KM, Tanaka T, Kawai K. Yamahara J et ilJ. Inhibitory effects of plumbagin and juglone on aJoxymethaneinduced intestinal carcinogenesis in rats. Cancer Lett 1998; 127: 177-183.
3. Susan T. Alam M. Purushothaman KK. Inhibitory activity of Arbortristoside A on fibrosarcoma in albino rats. Arogya J Health Sci 1986: 7: 122-130.
4. Mohana K, Purushothaman KK. Anticancer activity of cchitamine chloride. J Res Ayur Siil 19X3: IV: 111-114.
5. Kamarajan P. Sekar N, Mathuram V. Govindasamy S. Antitumour effect of cchitamine chloride on methylcholanthrene-induccd fibrosarcoma in rats. Rim-hem hit 1991: 25: 491-498.
6. Kamarajan P. Sekar N, Govindasamy S. Anticancer effect of echitamine chloride on plasma vitamins and minerals in rals with inethylcholanthrene induced fihrosarcoma. Metl Sci Ra, 1995: 23: 237-239.
7. Manonmani S, William S. Subramanian S. Govindasaiii) S. Biochemical evaluation ol'the antiulcerogcnic eft'ect of eauvery-100 (an ayurvedic formulation) in rats. J luint>phaniiac<>l 1994: 42: 1-5.
8. Kirtikar KR, Basil BD. An ICS. In: Indian Medicinal Plants Vol. IV. Council of Scientific and Industrial Research. Periodical experts. Delhi: Jayyed Press: 1975 pp. 1947. 2128. 2140. 235S.
9. Kirtikar KR. Basil BD. An ICS. In: Indian Medicinal l'Inné Vol II: Council of Scientific and Industrial Research. Periodical experts. Delhi: Jayyed Press; 1975. p. 275.
10. Warner PK, NamhiarVPK. Ramankutty C. In: Indian Medicinal Plann, Vol. II. Chennai: Orient Longman Limited. Indcom Press; 1995. pp.121-126.
11. Nagarajan B. Sankaran S. A rapid method for the production of fibrosarcoma. I ml J Cancer 1973; 10: 83-84.
12. Gcran RI. Greenberg NH. Macdonald MM. Sehunacher AM. Protocols for screening chemical agents and natural products against animal tumours and other biological systems. Cancer Chentotlter ReJ> 1972; 3: 103-108.
13. Jacobs W. A colorimetric assay for y-glutamyl transpeptidase. Clin ChimActa 1971; 31: 175-179.
14. King J. In: Practical Clinical Enzymology. London: Van Nostrand Company Limited; 1965. pp. 83-89.
15. Mohur AF, Cook IJY. Simple methods of measuring serum levels of the glutamic-oxaloaeetate and glutamic-pyruvate transaminases in routine laboratories. J Clin Pathol 1957; 10: 394-399.
16. King J. In: Practical Clinical En:.ymol<>J>\ London: Van Noslrand Company Limited: 1965. pp. 191-208.
17. Okinaka S. Kundyi A, Ebashi S. Sugita H. Morbri H. Toyokura Y. et al. A colorimetric assay forcreatine phosphokinase. Arch Neumlogv 1961 ; 41: 250-254.
18. Weinberg ED. Alterations in total iron, zinc, and calcium levels and their influence on the hepatic activities of y-GT and glucose-6-phosphatase in the host bearing transplantable murine lymphoma. Cancer Invest 1998: 16: 291-292.
19. Balasubramanian N. Subramanian S. Govindasamy S. Role of serum enzymes in assessing (he efficacy of radiation therapy for human carcinoma of uterine cervix. J din lliochem Nuir 1495; 19: 97 105.
20. Saraswathi V. Raiiuimoorthy N. Subramanlan S. Vlathuruni V. Gunasekuran P. Govindasamy S. Inhibition of plycolysis and respiration of sarcoma-1 SO cells by echitamine chloride. Clwtnothcrtipv 1998; 44: 198-205.
21. Hannisdal H. Solheim OP. Theodorseil L. Host (I. Alterations of blood analyses at relapse of osteosarcoma and Ewing's sarcoma. Acta Oncol 1990: 29: 5X5-5X7.
22. Engan T, Hannisdal K. Blood analyses as prognostic factors in primary lung cancer. Ada Oncol 1990: 29:' 151-154.
23. Ahn YS, Chemeris GY. Turusov SV, Bannasch P. KnJ.ymic pattern of preneoplastic and neoplastic lesions induced in the kidney of CBA mice by 1,2-dimelhylhydrazine. Toxicol Pmliol 1994: 22: 415-422.
24. AkaJa H. Isaka S. Usami M, Kanetake H. Kotake T. Koiso K et al. Recommended dose of flutumide with LH-RH against therapy in patients with advanced prostate cancer. Im J Ural 1996: 3: 468-471.
25. Berruti A, Cerutti S. Fasolis G, Sperone P, Tarabozzi R. Bertetto O et cil. Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone métastases submitted to systemic therapy. Anticancer Res 1997: 17: 4697-4702.
26. Patel SP, Rawal NG. Balar DB. Combined use of serum enzyme levels as tumour markers in clinical carcinoma patients. Tumor Biol 1994; 15: 45-51.
27. Buchs N, Bonjour JP. Rizzoli R. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer. .J din Endocrinol Melab 1998: 83: 1535-1541.
28. Jaques G, Bepler G, Holle R, Wolf M, Hannich T, Gropp C et al. Prognostic value of pretreatment carcinoembryonic antigen, neuron specific enolase. and creatine kinase-BB levels in sera of patients with small cell lung cancer. Cancer 1988; 62: 125-134.
29. Cersosimo RJ. Creatine kinase elevation associated with 5-Fluorouracil and levamisole therapy for carcinoma of the colon. Cancer 1996; 77: 1250-1253.